Cargando…

Feasibility and safety of definite volumetric modulated arc therapy with simultaneous integrated boost to the dominant intraprostatic lesion in patients with unfavorable intermediate to high-risk prostate cancer

BACKGROUND: The most common site of recurrence of prostate cancer after definite radiation therapy is the dominant intraprostatic lesion (DIL). This study aimed to investigate the feasibility and safety of definite volumetric modulated arc therapy (VMAT) with simultaneous integrated boost (SIB) to t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dankulchai, Pittaya, Sittiwong, Wiwatchai, Teerasamit, Wanwarang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Via Medica 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9591036/ https://www.ncbi.nlm.nih.gov/pubmed/36299386 http://dx.doi.org/10.5603/RPOR.a2022.0041

Ejemplares similares

Enhanced Deep-Learning-Based Automatic Left-Femur Segmentation Scheme with Attribute Augmentation
por: Apivanichkul, Kamonchat, et al.
Publicado: (2023)

Radiotherapy planning in a prostate cancer phantom model with intraprostatic dominant lesions using stereotactic body radiotherapy with volumetric modulated arcs and a simultaneous integrated boost
por: Skrobala, Agnieszka, et al.
Publicado: (2023)

Prostate Stereotactic Ablative Radiation Therapy Using Volumetric Modulated Arc Therapy to Dominant Intraprostatic Lesions()
por: Murray, Louise J., et al.
Publicado: (2014)

Dosimetric Evaluation of PSMA PET-Delineated Dominant Intraprostatic Lesion Simultaneous Infield Boosts
por: Goodman, Christopher D., et al.
Publicado: (2019)

Dosimetric Uncertainties in Dominant Intraprostatic Lesion Simultaneous Boost Using Intensity Modulated Proton Therapy
por: Zhou, Jun, et al.
Publicado: (2021)

Volumetric and Voxel-Wise Analysis of Dominant Intraprostatic Lesions on Multiparametric MRI
por: Lee, Joon, et al.
Publicado: (2019)

Feasibility of biology-guided radiotherapy using PSMA-PET to boost to dominant intraprostatic tumour
por: Gaudreault, Mathieu, et al.
Publicado: (2022)

Simultaneous integrated boost with stereotactic radiotherapy for dominant intraprostatic lesion of localized prostate cancer: a dosimetric planning study
por: Kim, Yeon Joo, et al.
Publicado: (2020)

MRS-guided HDR brachytherapy boost to the dominant intraprostatic lesion in high risk localised prostate cancer
por: Kazi, Aleksandra, et al.
Publicado: (2010)

Impact of multileaf collimator width on intraprostatic dose painting plans for dominant intraprostatic lesion of prostate cancer
por: Abe, Eisuke, et al.
Publicado: (2010)

Preoperative Volumetric Modulated Arc Therapy With Simultaneous Integrated Boost for Locally Advanced Distal Rectal Cancer
por: Yang, Yongqiang, et al.
Publicado: (2019)

Malignant Pericardial Mesothelioma Treated Using Volumetric Modulated Arc Therapy With a Simultaneous Integrated Boost
por: Steber, Cole, et al.
Publicado: (2020)

3 Tesla multiparametric MRI for GTV-definition of Dominant Intraprostatic Lesions in patients with Prostate Cancer – an interobserver variability study
por: Rischke, Hans Christian, et al.
Publicado: (2013)

Simultaneous Integrated Boost Volumetric Modulated Arc Therapy for Rectal Cancer: Long-Term Results after Protocol-Based Treatment
por: Lee, Dong Soo, et al.
Publicado: (2022)

Excess dose-related parameters (Vex, Rex, and iRex): novel predictors and late toxicity correlations in cervical cancer image-guided adaptive brachytherapy
por: Prasartseree, Tissana, et al.
Publicado: (2020)

Dosimetric Comparison between Single and Dual Arc-Volumetric Modulated Arc Radiotherapy and Intensity Modulated Radiotherapy for Nasopharyngeal Carcinoma Using a Simultaneous Integrated Boost Technique
por: Radhakrishnan, Sivakumar, et al.
Publicado: (2017)

Neoadjuvant volumetric modulated arc radiochemotherapy with a simultaneous integrated boost technique compared to standard chemoradiation for locally advanced rectal cancer
por: JANKARASHVILI, Natalia, et al.
Publicado: (2019)

Volumetry of the dominant intraprostatic tumour lesion: intersequence and interobserver differences on multiparametric MRI
por: Harvey, Hugh, et al.
Publicado: (2017)

The Intraprostatic Immune Environment after Stereotactic Body Radiotherapy is Dominated by Myeloid Cells
por: Nickols, Nicholas G., et al.
Publicado: (2020)

Comparison of impact of target delineation of computed tomography- and magnetic resonance imaging-guided brachytherapy on dose distribution in cervical cancer
por: Tuntipumiamorn, Lalida, et al.
Publicado: (2018)

End-to-end test and MOSFET in vivo skin dosimetry for (192)Ir high-dose-rate brachytherapy of chronic psoriasis
por: Tuntipumiamorn, Lalida, et al.
Publicado: (2019)

3D Kinect Camera Scheme with Time-Series Deep-Learning Algorithms for Classification and Prediction of Lung Tumor Motility
por: Puangragsa, Utumporn, et al.
Publicado: (2022)

Dosimetric Comparison and Feasibility of Simultaneous Integrated Boost (SIB) in Treatment of Malignant Gliomas Using Intensity Modulated Radiotherapy (IMRT) or Volumetric Modulated Arc Therapy (VMAT)
por: Rapole, Pragna Sagar, et al.
Publicado: (2018)

Toxicity profile and early clinical outcome for advanced head and neck cancer patients treated with simultaneous integrated boost and volumetric modulated arc therapy
por: Franzese, Ciro, et al.
Publicado: (2015)

Application of Volumetric Modulated Arc Therapy and Simultaneous Integrated Boost Techniques to Prepare “Safe Margin” in the Rabbit VX2 Limb Tumor Model
por: Wang, Chong-Wen, et al.
Publicado: (2015)

The patient-reported outcome measures in oropharyngeal, laryngeal and hypopharyngeal cancer patients treated with Volumetric Modulated Arc based simultaneous integrated boost radiotherapy
por: Elumalai, Thiraviyam, et al.
Publicado: (2021)

Prostate irradiation with focal dose escalation to the intraprostatic dominant nodule: a systematic review
por: Feutren, Thomas, et al.
Publicado: (2018)

Feasibility of Four-dimensional Adaptation of Volumetric Modulated Arc Therapy Based on Volumetric Modulated Arc Therapy-computed Tomography
por: Zhao, Xiaodong, et al.
Publicado: (2023)

Simultaneous in-field boost for patients with 1 to 4 brain metastasis/es treated with volumetric modulated arc therapy: a prospective study on quality-of-life
por: Weber, Damien C, et al.
Publicado: (2011)

Simultaneous integrated boost radiotherapy for bilateral breast: a treatment planning and dosimetric comparison for volumetric modulated arc and fixed field intensity modulated therapy
por: Nicolini, Giorgia, et al.
Publicado: (2009)

Ten Year Results of Extensive Nodal Radiotherapy and Moderately Hypofractionated Simultaneous Integrated Boost in Unfavorable Intermediate-, High-, and Very High-Risk Prostate Cancer
por: Di Muzio, Nadia Gisella, et al.
Publicado: (2021)

A RapidArc planning strategy for prostate with simultaneous integrated boost
por: Jolly, David, et al.
Publicado: (2010)

Determination of Intraprostatic and Intratesticular Androgens
por: Šimková, Markéta, et al.
Publicado: (2021)

Predictive ability of CT findings in the differentiation of complicated and uncomplicated appendicitis: a retrospective investigation of 201 patients undergone appendectomy at initial admission
por: Iamwat, Jidapa, et al.
Publicado: (2021)

Risk-Adaptive Volumetric Modulated Arc Therapy Using Biological Objective Functions for Subvolume Boosting in Radiotherapy
por: Hardcastle, Nicholas, et al.
Publicado: (2012)

Post-Operative Accelerated-Hypofractionated Chemoradiation With Volumetric Modulated Arc Therapy and Simultaneous Integrated Boost in Glioblastoma: A Phase I Study (ISIDE-BT-2)
por: Ferro, Marica, et al.
Publicado: (2021)

Phase I study of dose escalation to dominant intraprostatic lesions using high-dose-rate brachytherapy
por: Chapman, Christopher H, et al.
Publicado: (2018)

Simultaneous integrated boost plan comparison of volumetric‐modulated arc therapy and sliding window intensity‐modulated radiotherapy for whole pelvis irradiation of locally advanced prostate cancer
por: Riou, Olivier, et al.
Publicado: (2013)

Sparing Organs at Risk with Simultaneous Integrated Boost Volumetric Modulated Arc Therapy for Locally Advanced Non-Small Cell Lung Cancer: An Automatic Treatment Planning Study
por: Wang, Daquan, et al.
Publicado: (2020)

Intraprostatic Hydatid Cyst: An Unusual Presentation
por: Nouira, Yassine, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_va2n4q7i3ff2boalv3jdks73tn